|Dr. Ken H. Young
The University of Texas MD Anderson Cancer Center, USA.
|Degree-Granting Education Zhejiang University School of Medicine, Zhejiang, China, MD, 1984, Medicine University of Lund School of Medicine, Malmo, Sweden, PhD, 1995, Department of Pathology and Laboratory Medicine Postgraduate Training Research Fellowship, Cardiovascular Hematology Program, University of Oklahoma Health Science Center, Oklahoma City, OK, 6/1995-6/1999 Clinical Residency, Oregon Health and Science University, Portland, OR, 7/1999-6/2003 Clinical Fellowship, University of Nebraska Medical Center, Omaha, NE, 7/2003-6/2004|
|1. Acute myelogenous leukemia - WHO classification and clinical issues 2. Peripheral T-cell lymphoma - Current WHO classification and new challenge 3. New WHO Classification of Lymphoid Neoplasms 4. Dendritic and Histiocytic Neoplasms - New WHO Classification and clinical issues 5. Myelodysplastic Syndrome - WHO Classification and new challenge 6. Automated Hematology Analysis 7. Molecular Diagnostics and Cytogenetics in Lymphoma and Leukemia Applications 8. Hodgkin lymphoma - Diagnosis, Differential Diagnosis and Molecular Mechanism 9. Bone Marrow and Peripheral Blood Pathology (AACLS lecture award) 10. Flow cytometry and its application in hematologic malignancies 11. Lymphoid Neoplasms ? Where we stand now for the standard care in the molecular century 12. Molecular mechanisms of DLBCL ? what relevant to the clinical management 13. EBV+ Lymphoma: Biology, Mechanism and Clinical Management|